Gilead Sciences (GILD)

Market Cap

$193.48B

Current · Retrieved: · USD

GILD logo

GILD Market Cap

Current$193.48B
GILD Market Cap ($862.15M → $193.48B · CAGR +16.9%)
High-resolution chart · PNG

GILD market cap history

Daily history. Dates identify market observations.

Gilead Sciences Market Cap — Daily history
DateMarket Cap
115,799,411,925
115,799,411,925
114,237,068,430
115,799,411,925
113,567,492,646
114,683,452,286
116,580,579,953
114,584,255,873
114,584,255,873
114,795,048,250
113,269,903,409
114,584,255,873
113,269,903,409
112,203,541,976
111,298,374,713
111,298,374,713
111,831,555,429
111,298,374,713
109,897,225,388
108,806,064,851
109,686,433,011
114,212,269,327
114,212,269,327
109,612,035,702
114,212,269,327
114,857,046,008
116,989,768,874
120,312,847,450
121,391,609,674
121,391,609,674
119,742,469,318
121,391,609,674
113,691,488,162
111,868,754,084
111,397,571,125
110,132,816,867
110,132,816,867
110,988,385,924
110,132,816,867
109,475,640,635
109,215,252,532
110,058,419,558
110,083,218,661
110,083,218,661
110,356,008,795
110,083,218,661
108,161,288,171
109,314,446,465
106,995,730,325
108,322,482,341
108,322,482,341
107,528,911,041
108,322,482,341
107,566,109,696
106,412,951,402
105,458,189,653
104,987,002,974
104,987,002,974
105,334,190,417
104,987,002,974
106,809,737,052
105,656,578,757
104,689,413,737
104,367,025,396
104,367,025,396
104,887,806,561
104,367,025,396
105,073,799,835
104,081,835,711
103,957,840,195
102,965,876,071
102,965,876,071
103,672,650,509
102,965,877,311
101,936,713,292
103,895,842,437
104,143,833,468
104,032,237,504
104,032,237,504
104,081,835,711
104,032,237,504
104,019,837,953
102,978,279,343
103,114,670,690
102,159,905,220
102,159,905,220
102,680,686,385
103,114,670,690
100,361,970,246
100,981,947,823
98,167,249,621
97,671,267,559
97,671,267,559
97,609,269,801
97,671,267,559
98,117,651,415
98,824,425,853
97,956,457,245
98,514,437,065
97,410,876,977
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.